Bron

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Haemophilia1 trial
• Type 1 diabetes1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Bioverativ, a Sanofi company1 trial
• Sanofi1 trial

Running trials

• Recruiting

  A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

  NCT07088068· Phase 3· Sanofi· Source

• Active, not recruiting

  Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

  NCT04644575· Phase 3· Bioverativ, a Sanofi company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes1 recruiting